- Release Date: 15/05/25 08:24
- Summary: PAR Receives US Ethics Approval for Phase 3
- Price Sensitive: Yes
- Download Document 153.91KB
- Forums
- ASX - By Stock
- Ann: PAR Receives US Ethics Approval for Phase 3
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
0.76%
!
33.3¢

Ann: PAR Receives US Ethics Approval for Phase 3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
33.3¢ |
Change
0.003(0.76%) |
Mkt cap ! $132.1M |
Open | High | Low | Value | Volume |
32.5¢ | 33.5¢ | 31.8¢ | $278.1K | 862.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 49154 | 33.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
33.5¢ | 47875 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 49154 | 0.330 |
6 | 56436 | 0.325 |
10 | 179618 | 0.320 |
12 | 64356 | 0.315 |
7 | 83272 | 0.310 |
Price($) | Vol. | No. |
---|---|---|
0.335 | 47875 | 3 |
0.340 | 4684 | 2 |
0.345 | 5429 | 2 |
0.350 | 17915 | 4 |
0.355 | 40209 | 5 |
Last trade - 13.58pm 07/08/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |